Detecting Minimal Residual Disease with ddPCR
Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition
Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition
Earn CE credits and learn how to overcome variability in flow injection, dried blood spot analysis, in our free webinar
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission
Simplexa™ GBS Direct molecular assay enables in vitro detection of Group B Streptococcus
Cloud-based solution automatically records, tracks and monitors laboratory consumables for clinical laboratories
Genomic analysis tools SIRIUS and MERCURY to be implemented into the Google Cloud Platform
Fully-automated BD Phoenix™ CPO Detect Test Receives U.S. FDA Clearance
Anti-Müllerian assay kit, MenoCheck, will help prevent complications associated with the onset on menopause
Expert in mass spectrometry for therapeutic drug monitoring shares research goals and future predictions
We interview a scientist whose team designed AAV vectors used in a successful gene therapy clinical trial, and highlight the key technologies that supported his efforts
Five color, high-performance immunohistochemistry multiplexing solution to advance biomarker studies
Lactate Scout 4 designed for use in the field as training companion for individuals and sports teams
Contract researchers and cancer biologists, Robert B. Harris, Ph.D., Thomas Reynolds, and Gregory A. Meyers, owners and founders of NEXT Molecular Analytics, have joined the DNA sequencing revolution. To keep up their research momentum, they consider a next big step — automation
Olympus AI algorithm could improve clinical pathology classifications
HeartMate 3 offers significant advancements for patients not eligible for a heart transplant
Findings reported at ASHG 2018 annual meeting describe new associations between environmental factors and pharmacogenes
Ready-to-use kits determine genomic characteristics of solid tumours
The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation
In vitro diagnostic device designed for dried blood spot analysis
MR Solutions displays latest PET-MRI system at WMIC
From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer
This intelligent surgical device is a cornerstone in the surgical removal of cancers